Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
600 participants
OBSERVATIONAL
2020-07-15
2029-08-08
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
As cancer progresses there are series of interactions between the tumour and the patient, producing both local and systemic effects. This altered state of illness can have multiple ill effects including weight loss, fatigue, increased symptom burden and reduction in physical function which all contribute to a reduced quality of life.
These areas are often studied in isolation, giving an incomplete picture. A detailed, holistic characterisation of this group of people does not exist.
A robust characterisation of people with incurable cancer will allow identification and prioritisation of future research and has the potential to inform new therapeutics and provide justification for treatments.
This study aims to collect information about symptoms and quality of life, weight loss and body composition, physical activity and the body's immune response to cancer.
Participants with incurable cancer will be recruited to the study from oncology and palliative medicine services in the UK. Participants will answer questionnaires about quality of life and symptoms, have bloods taken for inflammatory marker and cytokine analysis and have their body composition measured by a variety of methods.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
CAncer, NUtrition and Taste 2
NCT05027490
Development of a Personalised Therapeutic Approach for Cancer Patients With Resting Hypermetabolism
NCT05281354
Enhancing Quality of Life in Cancer Patients Through Tailored Nutrition Support: a Comprehensive Approach
NCT06628141
Feasibility of Health Coaching in Cancer Patients
NCT02556528
Body Mass Index (BMI) and Quality of Life (QoL) in Cancer Patients
NCT03873064
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Aged 18-years and over
* Written informed consent
Exclusion Criteria
* Participants will not be able to take part in bio-impedance analysis if they have a pacemaker or implantable cardiac defibrillator.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
NHS Lothian
OTHER_GOV
University of Edinburgh
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Barry JA Laird, MBCHB MD
Role: PRINCIPAL_INVESTIGATOR
St Columba's Hospice/ University of Edinburgh
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
St Columba's Hospice
Edinburgh, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
References
Explore related publications, articles, or registry entries linked to this study.
Paval DR, Patton R, McDonald J, Skipworth RJE, Gallagher IJ, Laird BJ; Caledonian Cachexia Collaborative. A systematic review examining the relationship between cytokines and cachexia in incurable cancer. J Cachexia Sarcopenia Muscle. 2022 Apr;13(2):824-838. doi: 10.1002/jcsm.12912. Epub 2022 Jan 25.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
AC19154
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.